0 XP   0   0   0

Themis Medicare Limited
Buy, Hold or Sell?

Should you buy, hold or sell Themis Medicare Limited?

I guess you are interested in Themis Medicare Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Themis Medicare Limited

Let's start. I'm going to help you getting a better view of Themis Medicare Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Themis Medicare Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Themis Medicare Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Themis Medicare Limited. The closing price on 2023-02-03 was INR1,260 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Themis Medicare Limited Daily Candlestick Chart
Themis Medicare Limited Daily Candlestick Chart
Summary









1. Valuation of Themis Medicare Limited




Current price per share

INR1,259.65

2. Growth of Themis Medicare Limited




Is Themis Medicare Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$35m$26.6m$8.4m24.0%

How much money is Themis Medicare Limited making?

Current yearPrevious yearGrowGrow %
Making money$8.8m$4.3m$4.5m51.0%
Net Profit Margin18.5%15.5%--

How much money comes from the company's main activities?

3. Financial Health of Themis Medicare Limited




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#230 / 705

Most Revenue
#133 / 705

Most Profit
#86 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Themis Medicare Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Themis Medicare Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 18.5% means that ₹0.18 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Themis Medicare Limited:

  • The MRQ is 18.5%. The company is making a huge profit. +2
  • The TTM is 18.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.5%TTM18.5%0.0%
TTM18.5%YOY15.5%+3.0%
TTM18.5%5Y9.2%+9.3%
5Y9.2%10Y6.3%+2.9%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ18.5%0.4%+18.1%
TTM18.5%0.3%+18.2%
YOY15.5%0.2%+15.3%
5Y9.2%-0.7%+9.9%
10Y6.3%-0.1%+6.4%
1.1.2. Return on Assets

Shows how efficient Themis Medicare Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • 17.0% Return on Assets means that Themis Medicare Limited generated ₹0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Themis Medicare Limited:

  • The MRQ is 17.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.0%TTM17.0%0.0%
TTM17.0%YOY9.6%+7.4%
TTM17.0%5Y6.8%+10.2%
5Y6.8%10Y4.8%+2.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ17.0%0.1%+16.9%
TTM17.0%0.1%+16.9%
YOY9.6%-0.1%+9.7%
5Y6.8%-0.2%+7.0%
10Y4.8%0.1%+4.7%
1.1.3. Return on Equity

Shows how efficient Themis Medicare Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • 25.4% Return on Equity means Themis Medicare Limited generated ₹0.25 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Themis Medicare Limited:

  • The MRQ is 25.4%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.4%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.4%TTM25.4%0.0%
TTM25.4%YOY16.3%+9.0%
TTM25.4%5Y11.0%+14.3%
5Y11.0%10Y10.0%+1.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ25.4%0.6%+24.8%
TTM25.4%0.4%+25.0%
YOY16.3%0.4%+15.9%
5Y11.0%-0.3%+11.3%
10Y10.0%0.1%+9.9%

1.2. Operating Efficiency of Themis Medicare Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Themis Medicare Limited is operating .

  • Measures how much profit Themis Medicare Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 26.4% means the company generated ₹0.26  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Themis Medicare Limited:

  • The MRQ is 26.4%. The company is operating very efficient. +2
  • The TTM is 26.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ26.4%TTM26.4%0.0%
TTM26.4%YOY22.7%+3.7%
TTM26.4%5Y15.4%+10.9%
5Y15.4%10Y11.2%+4.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ26.4%2.5%+23.9%
TTM26.4%1.6%+24.8%
YOY22.7%2.7%+20.0%
5Y15.4%1.8%+13.6%
10Y11.2%0.8%+10.4%
1.2.2. Operating Ratio

Measures how efficient Themis Medicare Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are ₹0.78 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Themis Medicare Limited:

  • The MRQ is 0.782. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.782. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.782TTM0.7820.000
TTM0.782YOY0.822-0.041
TTM0.7825Y0.883-0.101
5Y0.88310Y0.895-0.012
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7821.473-0.691
TTM0.7821.456-0.674
YOY0.8221.398-0.576
5Y0.8831.374-0.491
10Y0.8951.191-0.296

1.3. Liquidity of Themis Medicare Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Themis Medicare Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.96 means the company has ₹1.96 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Themis Medicare Limited:

  • The MRQ is 1.955. The company is able to pay all its short-term debts. +1
  • The TTM is 1.955. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.955TTM1.9550.000
TTM1.955YOY1.446+0.510
TTM1.9555Y1.347+0.608
5Y1.34710Y1.201+0.146
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9551.880+0.075
TTM1.9551.901+0.054
YOY1.4462.112-0.666
5Y1.3472.182-0.835
10Y1.2011.891-0.690
1.3.2. Quick Ratio

Measures if Themis Medicare Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 1.31 means the company can pay off ₹1.31 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Themis Medicare Limited:

  • The MRQ is 1.314. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.314. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.314TTM1.3140.000
TTM1.314YOY0.930+0.385
TTM1.3145Y0.830+0.484
5Y0.83010Y0.580+0.251
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3140.733+0.581
TTM1.3140.796+0.518
YOY0.9300.808+0.122
5Y0.8300.834-0.004
10Y0.5800.821-0.241

1.4. Solvency of Themis Medicare Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Themis Medicare Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Themis Medicare Limited to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Themis Medicare Limited assets are financed with 32.8% credit (debt) and the remaining percentage (100% - 32.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Themis Medicare Limited:

  • The MRQ is 0.328. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.328. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.328TTM0.3280.000
TTM0.328YOY0.411-0.083
TTM0.3285Y0.432-0.104
5Y0.43210Y0.588-0.156
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3280.437-0.109
TTM0.3280.424-0.096
YOY0.4110.398+0.013
5Y0.4320.398+0.034
10Y0.5880.401+0.187
1.4.2. Debt to Equity Ratio

Measures if Themis Medicare Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 48.8% means that company has ₹0.49 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Themis Medicare Limited:

  • The MRQ is 0.488. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.488. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.488TTM0.4880.000
TTM0.488YOY0.699-0.211
TTM0.4885Y0.779-0.291
5Y0.77910Y1.987-1.208
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4880.652-0.164
TTM0.4880.675-0.187
YOY0.6990.623+0.076
5Y0.7790.684+0.095
10Y1.9870.697+1.290

2. Market Valuation of Themis Medicare Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Themis Medicare Limited generates.

  • Above 15 is considered overpriced but always compare Themis Medicare Limited to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of 11.83 means the investor is paying ₹11.83 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Themis Medicare Limited:

  • The EOD is 15.901. Very good. +2
  • The MRQ is 11.830. Very good. +2
  • The TTM is 11.830. Very good. +2
Trends
Current periodCompared to+/- 
EOD15.901MRQ11.830+4.072
MRQ11.830TTM11.8300.000
TTM11.830YOY7.250+4.580
TTM11.8305Y9.695+2.135
5Y9.69510Y13.506-3.811
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD15.901-0.124+16.025
MRQ11.830-0.437+12.267
TTM11.830-0.102+11.932
YOY7.25015.340-8.090
5Y9.6957.916+1.779
10Y13.5067.700+5.806
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Themis Medicare Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Themis Medicare Limited:

  • The MRQ is 5.795. Seems overpriced? -1
  • The TTM is 5.795. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ5.795TTM5.7950.000
TTM5.795YOY5.032+0.763
TTM5.7955Y20.727-14.932
5Y20.72710Y15.934+4.793
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7950.012+5.783
TTM5.7950.010+5.785
YOY5.0320.004+5.028
5Y20.7270.010+20.717
10Y15.9340.021+15.913

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Themis Medicare Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 3.00 means the investor is paying ₹3.00 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Themis Medicare Limited:

  • The EOD is 4.031. Neutral. Compare to industry.
  • The MRQ is 2.999. Good. +1
  • The TTM is 2.999. Good. +1
Trends
Current periodCompared to+/- 
EOD4.031MRQ2.999+1.032
MRQ2.999TTM2.9990.000
TTM2.999YOY1.185+1.814
TTM2.9995Y2.034+0.965
5Y2.03410Y2.320-0.287
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD4.0311.415+2.616
MRQ2.9991.586+1.413
TTM2.9992.019+0.980
YOY1.1852.230-1.045
5Y2.0341.895+0.139
10Y2.3201.505+0.815
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Themis Medicare Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--74.97874.9780%38.566+94%36.521+105%24.935+201%
Book Value Growth--1.3161.3160%1.194+10%1.201+10%1.189+11%
Book Value Per Share--312.478312.4780%237.500+32%220.851+41%150.336+108%
Book Value Per Share Growth--1.3161.3160%1.194+10%1.203+9%1.189+11%
Current Ratio--1.9551.9550%1.446+35%1.347+45%1.201+63%
Debt To Asset Ratio--0.3280.3280%0.411-20%0.432-24%0.588-44%
Debt To Equity Ratio--0.4880.4880%0.699-30%0.779-37%1.987-75%
Dividend Per Share--4.3004.3000%1.748+146%2.258+90%1.539+179%
Dividend Per Share Growth--2.4602.4600%1.000+146%1.365+80%1.086+127%
Eps--79.21679.2160%38.806+104%29.111+172%18.495+328%
Eps Growth--2.0412.0410%1.441+42%1.510+35%1.787+14%
Free Cash Flow Per Share--14.96314.9630%42.321-65%11.033+36%6.952+115%
Free Cash Flow Per Share Growth--0.3540.3540%9.107-96%3.065-88%2.612-86%
Free Cash Flow To Equity Per Share---4.109-4.1090%14.444-128%-1.035-75%3.000-237%
Free Cash Flow To Equity Per Share Growth---0.284-0.2840%10.660-103%0.620-146%0.725-139%
Gross Profit Margin--1.0001.0000%0.582+72%0.840+19%0.785+27%
Intrinsic Value_10Y_max--405.146--------
Intrinsic Value_10Y_min--273.645--------
Intrinsic Value_1Y_max--22.224--------
Intrinsic Value_1Y_min--18.290--------
Intrinsic Value_3Y_max--80.777--------
Intrinsic Value_3Y_min--63.188--------
Intrinsic Value_5Y_max--156.214--------
Intrinsic Value_5Y_min--116.766--------
Net Profit Margin--0.1850.1850%0.155+19%0.092+102%0.063+193%
Operating Margin--0.2640.2640%0.227+16%0.154+71%0.112+136%
Operating Ratio--0.7820.7820%0.822-5%0.883-11%0.895-13%
Pb Ratio4.031+26%2.9992.9990%1.185+153%2.034+47%2.320+29%
Pe Ratio15.901+26%11.83011.8300%7.250+63%9.695+22%13.506-12%
Peg Ratio--5.7955.7950%5.032+15%20.727-72%15.934-64%
Price Per Share1259.650+26%937.100937.1000%281.350+233%463.040+102%354.370+164%
Price To Total Gains Ratio15.889+26%11.82011.8200%6.979+69%1.530+673%7.754+52%
Profit Growth--2.0412.0410%1.441+42%1.484+38%1.877+9%
Quick Ratio--1.3141.3140%0.930+41%0.830+58%0.580+127%
Return On Assets--0.1700.1700%0.096+77%0.068+150%0.048+254%
Return On Equity--0.2540.2540%0.163+55%0.110+130%0.100+155%
Revenue Growth--1.7111.7110%1.144+50%1.136+51%1.115+53%
Total Gains Per Share--79.27879.2780%40.314+97%38.779+104%26.474+199%
Total Gains Per Share Growth--1.9671.9670%1.397+41%1.867+5%2.326-15%
Usd Book Value--35073584.80035073584.8000%26657756.400+32%24789089.720+41%16886081.000+108%
Usd Book Value Change Per Share--0.9150.9150%0.471+94%0.446+105%0.304+201%
Usd Book Value Per Share--3.8123.8120%2.897+32%2.694+41%1.834+108%
Usd Dividend Per Share--0.0520.0520%0.021+146%0.028+90%0.019+179%
Usd Eps--0.9660.9660%0.473+104%0.355+172%0.226+328%
Usd Free Cash Flow--1679549.6001679549.6000%4750228.600-65%1238431.760+36%778717.460+116%
Usd Free Cash Flow Per Share--0.1830.1830%0.516-65%0.135+36%0.085+115%
Usd Free Cash Flow To Equity Per Share---0.050-0.0500%0.176-128%-0.013-75%0.037-237%
Usd Price Per Share15.368+26%11.43311.4330%3.432+233%5.649+102%4.323+164%
Usd Profit--8891457.6008891457.6000%4355766.000+104%3267672.400+172%2138824.700+316%
Usd Revenue--48142920.20048142920.2000%28141715.600+71%29771176.880+62%27683909.380+74%
Usd Total Gains Per Share--0.9670.9670%0.492+97%0.473+104%0.323+199%
 EOD+2 -3MRQTTM+0 -0YOY+32 -115Y+36 -710Y+36 -7

3.2. Fundamental Score

Let's check the fundamental score of Themis Medicare Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.901
Price to Book Ratio (EOD)Between0-14.031
Net Profit Margin (MRQ)Greater than00.185
Operating Margin (MRQ)Greater than00.264
Quick Ratio (MRQ)Greater than11.314
Current Ratio (MRQ)Greater than11.955
Debt to Asset Ratio (MRQ)Less than10.328
Debt to Equity Ratio (MRQ)Less than10.488
Return on Equity (MRQ)Greater than0.150.254
Return on Assets (MRQ)Greater than0.050.170
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Themis Medicare Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.832
Ma 20Greater thanMa 501,245.128
Ma 50Greater thanMa 1001,227.499
Ma 100Greater thanMa 2001,099.563
OpenGreater thanClose1,234.750
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-03-312019-03-312020-03-312021-03-312022-03-31
Minority Interest  -630455-175170-5-1-671



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets4,277,805
Total Liabilities1,402,921
Total Stockholder Equity2,874,891
 As reported
Total Liabilities 1,402,921
Total Stockholder Equity+ 2,874,891
Total Assets = 4,277,805

Assets

Total Assets4,277,805
Total Current Assets2,141,560
Long-term Assets2,141,560
Total Current Assets
Cash And Cash Equivalents 202,793
Short-term Investments 111,616
Net Receivables 1,013,299
Inventory 608,094
Total Current Assets  (as reported)2,141,560
Total Current Assets  (calculated)1,935,802
+/- 205,758
Long-term Assets
Property Plant Equipment 1,455,741
Intangible Assets 9,888
Long-term Assets Other 210,818
Long-term Assets  (as reported)2,136,245
Long-term Assets  (calculated)1,676,447
+/- 459,798

Liabilities & Shareholders' Equity

Total Current Liabilities1,095,186
Long-term Liabilities307,735
Total Stockholder Equity2,874,891
Total Current Liabilities
Short-term Debt 554,313
Short Long Term Debt 546,678
Accounts payable 318,738
Other Current Liabilities 222,135
Total Current Liabilities  (as reported)1,095,186
Total Current Liabilities  (calculated)1,641,864
+/- 546,678
Long-term Liabilities
Long term Debt Total 243,011
Other Liabilities 64,724
Long-term Liabilities  (as reported)307,735
Long-term Liabilities  (calculated)307,735
+/-0
Total Stockholder Equity
Common Stock92,003
Other Stockholders Equity 2,782,888
Total Stockholder Equity (as reported)2,874,891
Total Stockholder Equity (calculated)2,874,891
+/-0
Other
Capital Stock92,003
Cash and Short Term Investments 314,409
Common Stock Shares Outstanding 9,191
Liabilities and Stockholders Equity 4,277,812
Net Debt 594,531
Net Invested Capital 3,660,389
Net Tangible Assets 2,865,003
Net Working Capital 1,046,374
Short Long Term Debt Total 797,324



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
2,313,921
2,727,409
2,943,783
2,760,661
2,939,892
2,795,909
2,734,012
2,849,147
2,793,141
2,761,449
3,097,708
3,052,711
3,141,095
3,499,134
3,711,401
4,277,805
4,277,8053,711,4013,499,1343,141,0953,052,7113,097,7082,761,4492,793,1412,849,1472,734,0122,795,9092,939,8922,760,6612,943,7832,727,4092,313,921
   > Total Current Assets 
1,264,136
1,586,485
1,548,064
1,420,773
1,574,070
1,290,066
1,236,664
1,356,625
1,353,925
1,336,015
1,605,821
1,430,617
1,498,631
1,804,913
1,854,695
2,141,560
2,141,5601,854,6951,804,9131,498,6311,430,6171,605,8211,336,0151,353,9251,356,6251,236,6641,290,0661,574,0701,420,7731,548,0641,586,4851,264,136
       Cash And Cash Equivalents 
162,926
216,448
138,636
150,525
75,792
69,093
120,139
68,650
86,929
148,510
101,336
44,850
17,547
33,415
190,180
202,793
202,793190,18033,41517,54744,850101,336148,51086,92968,650120,13969,09375,792150,525138,636216,448162,926
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
33
37,723
39,043
33
109,352
111,616
111,616109,3523339,04337,723330000000000
       Net Receivables 
0
0
0
0
0
0
0
441,466
495,472
232,826
490,217
693,945
736,744
1,032,515
783,765
1,013,299
1,013,299783,7651,032,515736,744693,945490,217232,826495,472441,4660000000
       Inventory 
366,526
441,087
546,024
425,995
465,593
477,033
547,063
662,355
628,304
584,697
643,398
495,753
536,349
546,089
584,944
608,094
608,094584,944546,089536,349495,753643,398584,697628,304662,355547,063477,033465,593425,995546,024441,087366,526
       Other Current Assets 
734,684
928,950
863,404
844,253
1,032,685
743,940
569,462
625,620
638,692
602,808
861,087
852,291
905,692
1,225,409
970,219
1,219,057
1,219,057970,2191,225,409905,692852,291861,087602,808638,692625,620569,462743,9401,032,685844,253863,404928,950734,684
   > Long-term Assets 
1,049,785
1,140,924
1,395,719
1,339,888
1,365,822
1,505,843
1,497,348
1,492,522
1,439,216
1,425,434
1,491,887
1,622,094
1,642,464
1,694,221
1,856,706
2,136,245
2,136,2451,856,7061,694,2211,642,4641,622,0941,491,8871,425,4341,439,2161,492,5221,497,3481,505,8431,365,8221,339,8881,395,7191,140,9241,049,785
       Property Plant Equipment 
978,548
1,066,692
1,377,858
1,312,393
1,360,751
1,379,327
1,347,331
1,327,167
1,256,444
1,199,281
1,169,242
1,265,117
1,242,166
1,224,240
1,343,712
1,455,741
1,455,7411,343,7121,224,2401,242,1661,265,1171,169,2421,199,2811,256,4441,327,1671,347,3311,379,3271,360,7511,312,3931,377,8581,066,692978,548
       Long Term Investments 
0
0
0
0
0
0
0
38,534
48,531
59,859
220,787
246,274
268,912
0
0
0
000268,912246,274220,78759,85948,53138,5340000000
       Intangible Assets 
0
0
0
0
0
1,849
0
1,700
1,786
22,992
20,808
18,624
16,440
14,256
12,072
9,888
9,88812,07214,25616,44018,62420,80822,9921,7861,70001,84900000
       Long-term Assets Other 
71,237
74,232
17,861
27,495
5,071
124,667
150,017
165,355
182,772
226,153
322,645
81,873
87,572
410,001
157,875
210,818
210,818157,875410,00187,57281,873322,645226,153182,772165,355150,017124,6675,07127,49517,86174,23271,237
> Total Liabilities 
1,622,321
1,881,480
2,025,135
1,927,235
2,029,627
2,215,120
2,196,843
2,287,299
2,204,062
1,972,561
1,893,105
1,364,161
1,560,368
1,668,894
1,526,339
1,402,921
1,402,9211,526,3391,668,8941,560,3681,364,1611,893,1051,972,5612,204,0622,287,2992,196,8432,215,1202,029,6271,927,2352,025,1351,881,4801,622,321
   > Total Current Liabilities 
739,230
708,532
710,950
630,947
734,551
1,493,510
1,206,910
1,362,741
1,357,844
1,285,685
1,322,229
1,247,883
1,466,858
1,548,102
1,283,061
1,095,186
1,095,1861,283,0611,548,1021,466,8581,247,8831,322,2291,285,6851,357,8441,362,7411,206,9101,493,510734,551630,947710,950708,532739,230
       Short-term Debt 
0
0
0
0
0
0
505,495
527,353
540,663
518,842
738,202
685,022
724,519
878,642
638,025
554,313
554,313638,025878,642724,519685,022738,202518,842540,663527,353505,495000000
       Short Long Term Debt 
0
0
0
0
0
0
0
1,477,012
115,758
121,946
736,393
684,111
763,377
874,598
569,278
546,678
546,678569,278874,598763,377684,111736,393121,946115,7581,477,0120000000
       Accounts payable 
0
0
0
0
0
0
514,733
570,692
593,019
536,296
351,474
305,517
350,401
296,831
307,919
318,738
318,738307,919296,831350,401305,517351,474536,296593,019570,692514,733000000
       Other Current Liabilities 
739,230
708,532
710,950
630,947
734,551
1,493,510
186,682
264,696
224,162
230,547
227,809
252,002
387,756
369,841
333,159
222,135
222,135333,159369,841387,756252,002227,809230,547224,162264,696186,6821,493,510734,551630,947710,950708,532739,230
   > Long-term Liabilities 
881,673
1,170,976
1,314,185
1,296,288
1,295,076
721,610
989,933
924,558
846,218
686,876
570,876
116,278
93,510
120,792
243,278
307,735
307,735243,278120,79293,510116,278570,876686,876846,218924,558989,933721,6101,295,0761,296,2881,314,1851,170,976881,673
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
283,078
124,020
114,972
93,510
118,545
233,795
243,011
243,011233,795118,54593,510114,972124,020283,078000000000
       Other Liabilities 
0
0
0
0
0
0
0
132,050
73,978
74,280
155,232
1,306
0
2,247
9,483
64,724
64,7249,4832,24701,306155,23274,28073,978132,0500000000
> Total Stockholder Equity
693,018
847,901
918,648
833,426
910,265
580,789
537,169
561,848
589,079
788,888
1,204,603
1,689,206
1,580,902
1,830,245
2,185,068
2,874,891
2,874,8912,185,0681,830,2451,580,9021,689,2061,204,603788,888589,079561,848537,169580,789910,265833,426918,648847,901693,018
   Common Stock
80,505
80,505
80,505
80,505
80,505
80,505
80,505
84,505
84,684
85,150
90,394
91,809
91,809
91,880
91,885
92,003
92,00391,88591,88091,80991,80990,39485,15084,68484,50580,50580,50580,50580,50580,50580,50580,505
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 00-299,528-220,004-144,360-1,043,073-947,257-838,849-706,507-610,861-541,857-467,184-389,860-353,481-278,890-218,700
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
831,213
1,046,286
1,191,624
1,142,781
1,296,944
1,042,141
1,067,525
1,183,850
1,343,244
1,650,995
2,157,282
1,532,261
1,604,312
1,681,354
1,375,942
2,782,888
2,782,8881,375,9421,681,3541,604,3121,532,2612,157,2821,650,9951,343,2441,183,8501,067,5251,042,1411,296,9441,142,7811,191,6241,046,286831,213



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue3,946,141
Cost of Revenue-1,481,394
Gross Profit2,464,7472,464,747
 
Operating Income (+$)
Gross Profit2,464,747
Operating Expense-1,603,195
Operating Income861,552861,552
 
Operating Expense (+$)
Research Development-
Selling General Administrative519,725
Selling And Marketing Expenses-
Operating Expense1,603,195519,725
 
Net Interest Income (+$)
Interest Income25,658
Interest Expense-87,745
Net Interest Income-87,745-62,087
 
Pretax Income (+$)
Operating Income861,552
Net Interest Income-87,745
Other Non-Operating Income Expenses-
Income Before Tax (EBT)952,620770,484
EBIT - interestExpense = 952,621
952,621
816,553
Interest Expense87,745
Earnings Before Interest and Taxes (ebit)1,040,3661,040,365
Earnings Before Interest and Taxes (ebitda)1,135,164
 
After tax Income (+$)
Income Before Tax952,620
Tax Provision-223,813
Net Income From Continuing Ops728,807728,807
Net Income728,808
Net Income Applicable To Common Shares728,808
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,084,589
Total Other Income/Expenses Net91,06887,745
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PFC.V
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PFC.V.

PFC.V Daily Candlestick Chart
0IAH.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IAH.LSE.

0IAH.LSE Daily Candlestick Chart
VUAG.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VUAG.LSE.

VUAG.LSE Daily Candlestick Chart
0I5O.LSE
23 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of 0I5O.LSE.

0I5O.LSE Daily Candlestick Chart
XDWE.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XDWE.LSE.

XDWE.LSE Daily Candlestick Chart
XACT-BULL-2.ST
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XACT-BULL-2.ST.

XACT-BULL-2.ST Daily Candlestick Chart
XACT-BULL.ST
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XACT-BULL.ST.

XACT-BULL.ST Daily Candlestick Chart
XACT-BEAR.ST
23 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XACT-BEAR.ST.

XACT-BEAR.ST Daily Candlestick Chart
WLDL.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WLDL.LSE.

WLDL.LSE Daily Candlestick Chart
UNIBAP.ST
23 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of UNIBAP.ST.

UNIBAP.ST Daily Candlestick Chart
S9I.XETRA
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of S9I.XETRA.

S9I.XETRA Daily Candlestick Chart
SGL.XETRA
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGL.XETRA.

SGL.XETRA Daily Candlestick Chart
TEQ.ST
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEQ.ST.

TEQ.ST Daily Candlestick Chart
TDGB.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TDGB.LSE.

TDGB.LSE Daily Candlestick Chart
SC04.XETRA
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SC04.XETRA.

SC04.XETRA Daily Candlestick Chart
SVIK.ST
23 hours ago

I found you a Bullish Engulfing Candle Pattern on the daily chart of SVIK.ST.

SVIK.ST Daily Candlestick Chart
PA8.XETRA
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PA8.XETRA.

PA8.XETRA Daily Candlestick Chart
SPEP.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPEP.LSE.

SPEP.LSE Daily Candlestick Chart
SP5L.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SP5L.LSE.

SP5L.LSE Daily Candlestick Chart
SLEEP.ST
23 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of SLEEP.ST.

SLEEP.ST Daily Candlestick Chart
SIVE.ST
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIVE.ST.

SIVE.ST Daily Candlestick Chart
SGEA.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGEA.LSE.

SGEA.LSE Daily Candlestick Chart
SECU-B.ST
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SECU-B.ST.

SECU-B.ST Daily Candlestick Chart
SBUY.LSE
23 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SBUY.LSE.

SBUY.LSE Daily Candlestick Chart